ArticleBiomedical optics express2025
Visible light optical coherence tomography for assessing retinal structure and function in diseased mouse models.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Ultrabroadband OCT for simultaneous visible and near-infrared light imaging of the mouse retina.Biomedical optics express · 2026Article
- Visible Light Optical Coherence Tomography: Technology and Biomedical Applications.Bioengineering (Basel, Switzerland) · 2025Review
- Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction to the feature issue.Biomedical optics express · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The measurement of retinal structure and function is critical for the early diagnosis of blinding eye diseases. Here, we develop a visible light OCT system that integrates high-resolution imaging, GPU-accelerated computing, and automated retinal layer segmentation algorithms that allow for three-dimensional high-definition retinal imaging and blood flow and oxygen saturation measurement for mouse models. We conducted a series of imaging experiments on diseased mouse models, including those with retinitis pigmentosa and glaucoma, and compared them with wild-type mice, and evaluated the OCT imaging results with histological analysis. We observed a reduction in retinal thickness in the retinitis pigmentosa model, along with damage to the inner/outer segment junctions and the outer nuclear layer. In the glaucoma model, the intensity of the ganglion cell layer relative to the internal limiting membrane was reduced. Both disease models exhibited decreased retinal arteriovenous and total blood flow, increased venous oxygen saturation, and a reduced arteriovenous oxygen saturation difference. We also compared the visible light OCT system with an 840 nm spectral domain OCT and a 1060 nm swept source OCT for mouse retinal imaging. The visualization and monitoring of retinal function and metabolic capacity using mouse models through visible light OCT may provide new opportunities for understanding the pathology of ocular diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.